EGF Theramed Health Corp.

CSE: TMED, OTC: EVAHF, FFT: AUHP

Company Logo

Company Overview

EGF Theramed Health Corp. is focused on improving delivery systems and creating a strong intellectual property portfolio around psilocybin. 

The company has two companies in its portfolio:

  • Pharmadelic Labs is a biotech company focused on improving and patenting engineering processes for the biosynthesis of compounds with a focus on psilocybin. EGF Theramed owns a 30% stake in Pharmadelic Labs.
  • Green Parrot Labs is a Caribbean-based company focused on psilocybin research and building a network of health centers dealing with treatment-resistant conditions—piggybacking on established medical tourism trends. EGF Theramed owns a 40% stake in Green Parrot Labs.

Financial Highlights

$0

Revenue (ttm)

-$220,000

Gross Profit (ttm)

-$12.43

Diluted EPS (ttm)

Management Team

Mr. Jatinder Dhaliwal
CEO & Director

Mr. Usama Chaudhry
CFO & Director

Mr. Brendan Purdy J.D., L.L.D.
Interim Chief Operating Officer of the Medical Blockchain & Data Security Division

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$983,248

Shares Outstanding
18,452,766

Shares Short (% of Float)
30,050 (0%)

Insider Ownership
0%